FR2978458B1 - Procede in vitro utilisant de la peau humaine pour evaluer l'influence des transporteurs abc - Google Patents

Procede in vitro utilisant de la peau humaine pour evaluer l'influence des transporteurs abc

Info

Publication number
FR2978458B1
FR2978458B1 FR1156939A FR1156939A FR2978458B1 FR 2978458 B1 FR2978458 B1 FR 2978458B1 FR 1156939 A FR1156939 A FR 1156939A FR 1156939 A FR1156939 A FR 1156939A FR 2978458 B1 FR2978458 B1 FR 2978458B1
Authority
FR
France
Prior art keywords
evaluate
influence
human skin
vitro method
abc transporters
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1156939A
Other languages
English (en)
Other versions
FR2978458A1 (fr
Inventor
Ponchet Hanan Osman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galderma Research and Development SNC
Original Assignee
Galderma Research and Development SNC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Research and Development SNC filed Critical Galderma Research and Development SNC
Priority to FR1156939A priority Critical patent/FR2978458B1/fr
Priority to PCT/FR2012/051476 priority patent/WO2013001232A1/fr
Priority to EP12738535.9A priority patent/EP2726878A1/fr
Priority to US14/130,268 priority patent/US9400283B2/en
Publication of FR2978458A1 publication Critical patent/FR2978458A1/fr
Application granted granted Critical
Publication of FR2978458B1 publication Critical patent/FR2978458B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6881—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from skin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR1156939A 2011-06-30 2011-07-29 Procede in vitro utilisant de la peau humaine pour evaluer l'influence des transporteurs abc Expired - Fee Related FR2978458B1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FR1156939A FR2978458B1 (fr) 2011-07-29 2011-07-29 Procede in vitro utilisant de la peau humaine pour evaluer l'influence des transporteurs abc
PCT/FR2012/051476 WO2013001232A1 (fr) 2011-06-30 2012-06-27 Procédé in vitro utilisant de la peau humaine pour évaluer l'influence des transporteurs ABC
EP12738535.9A EP2726878A1 (fr) 2011-06-30 2012-06-27 Procédé in vitro utilisant de la peau humaine pour évaluer l'influence des transporteurs abc
US14/130,268 US9400283B2 (en) 2011-06-30 2012-06-27 In vitro method using human skin for evaluating the influence of ABC transporters

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1156939A FR2978458B1 (fr) 2011-07-29 2011-07-29 Procede in vitro utilisant de la peau humaine pour evaluer l'influence des transporteurs abc

Publications (2)

Publication Number Publication Date
FR2978458A1 FR2978458A1 (fr) 2013-02-01
FR2978458B1 true FR2978458B1 (fr) 2015-02-13

Family

ID=47423479

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1156939A Expired - Fee Related FR2978458B1 (fr) 2011-06-30 2011-07-29 Procede in vitro utilisant de la peau humaine pour evaluer l'influence des transporteurs abc

Country Status (4)

Country Link
US (1) US9400283B2 (fr)
EP (1) EP2726878A1 (fr)
FR (1) FR2978458B1 (fr)
WO (1) WO2013001232A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018065384A1 (fr) * 2016-10-03 2018-04-12 Galderma Research & Development Profils d'expression de transporteurs abc et slc dans la peau, le foie et le rein d'êtres humains et de miniporcs
EP3973271A1 (fr) 2018-09-14 2022-03-30 Unilever IP Holdings B.V. Évaluation de l'efficacité de compositions cosmétiques sans rinçage à protéger contre les polluants

Also Published As

Publication number Publication date
FR2978458A1 (fr) 2013-02-01
EP2726878A1 (fr) 2014-05-07
US20140162291A1 (en) 2014-06-12
WO2013001232A1 (fr) 2013-01-03
US9400283B2 (en) 2016-07-26

Similar Documents

Publication Publication Date Title
IL282219B (en) Humanized antibodies to pcsk9 for use in the treatment of certain groups of people
CO7020878A2 (es) Terapia combinada de anticuerpos contra el csf-1r humano y las utilizaciones de la misma
PL3738434T3 (pl) Związki pośrednie do otrzymywania podstawionych związków benzaldehydowych i sposoby ich zastosowania do zwiększania natlenienia tkanek
UY33863A (es) Metodos y medicamentos para el tratamiento de la enfermedad de alzheimer
PL2704704T3 (pl) Bakterie probiotyczne do miejscowego leczenia zaburzeń skóry
IL232256A0 (en) Purine derivatives and their use in the treatment of diseases
HRP20150117T1 (en) Collagenase g and collagenase h compositions for the treatment of diseases involving alterations of collagen
EP3628326C0 (fr) Méthodes et substances permettant de traiter la maladie de pompe
IL234606B (en) Innovative methods and compounds for the treatment of diseases
SMT201600036B (it) Metodo per la preparazione e il miglioramento di ferri di cavallo
EP2770832A4 (fr) Compositions et procédés de stimulation de synthèse de collagène dans la peau
IT1403842B1 (it) Procedimento per il trattamento e la vinificazione dell'uva
IT1406864B1 (it) Composizione per il trattamento dell'acne
EP2709632A4 (fr) Compositions et procédés pour le traitement de maladies de la peau
FR2978458B1 (fr) Procede in vitro utilisant de la peau humaine pour evaluer l'influence des transporteurs abc
GB201114289D0 (en) Flurbiprofen and related compounds for the treatment of skin diseases
FR2950074B1 (fr) Equivalent de peau in vitro et procede de preparation
FR2957788B1 (fr) Procede cosmetique topique utilisant un microorganisme probiotique vivant
FR2957763B1 (fr) Procede de traitement cosmetique de la peau.
PT3395836T (pt) Anticorpos humanos para pcsk9 para uso em métodos de tratar grupos específicos de sujeitos
SM201100027A (it) Metodo e composizione per il trattamento di inestitismi cutanei
CO6970562A2 (es) Dispositivo y método para ayudar en el tratamiento de córnea
ES1072327Y (es) Pieza para la formacion de pendientes en tabiques palomeros
ES1079605Y (es) Compostador de subproductos animales no destinados al consumo humano procedentes de la acuicultura
FR2979237B1 (fr) Procede de depigmentation de la peau

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20160331